Evidence map›Paper›PMID 41989482›Full record

ReviewApplied microbiology and biotechnology2026

Structural and mechanistic insights into the divergence of pterin deaminase and sepiapterin deaminase.

Nivetha Shanmuganathan, Sasireka Manikandan, Jerimon Johnson, Sabaridaran Balasubramani, Angayarkanni Jayaraman, Sruthi Paleri, Theertha Ranjith, Thasleema Parveen A

Abstract readReview
In one paragraph

Review in Applied microbiology and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Nivetha ShanmuganathanCancer Therapeutics Laboratory, Department of Microbial Biotechnology, Bharathiar University, Coimbatore, 41046, Tamil Nadu, India.
Sasireka ManikandanCancer Therapeutics Laboratory, Department of Microbial Biotechnology, Bharathiar University, Coimbatore, 41046, Tamil Nadu, India.
Jerimon JohnsonCancer Therapeutics Laboratory, Department of Microbial Biotechnology, Bharathiar University, Coimbatore, 41046, Tamil Nadu, India.
Sabaridaran BalasubramaniCancer Therapeutics Laboratory, Department of Microbial Biotechnology, Bharathiar University, Coimbatore, 41046, Tamil Nadu, India.
Angayarkanni JayaramanCancer Therapeutics Laboratory, Department of Microbial Biotechnology, Bharathiar University, Coimbatore, 41046, Tamil Nadu, India. angaibiotech@buc.edu.in.
Sruthi PaleriCancer Therapeutics Laboratory, Department of Microbial Biotechnology, Bharathiar University, Coimbatore, 41046, Tamil Nadu, India.
Theertha RanjithCancer Therapeutics Laboratory, Department of Microbial Biotechnology, Bharathiar University, Coimbatore, 41046, Tamil Nadu, India.
Thasleema Parveen ACancer Therapeutics Laboratory, Department of Microbial Biotechnology, Bharathiar University, Coimbatore, 41046, Tamil Nadu, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pterin deaminase and sepiapterin deaminase are key members of the amidohydrolase superfamily and play essential roles in pteridine metabolism across a wide range of biological systems. Pterin deaminase catalyzes the deamination of pterins, contributing to the regulation of purine and pyrimidine metabolism, whereas sepiapterin deaminase is specifically involved in the degradation of sepiapterin, a critical intermediate in the tetrahydrobiopterin (BH4) biosynthetic pathway. These enzymes are distributed throughout prokaryotic and eukaryotic organisms and display diverse substrate specificity, metal dependency, and enzymatic stability. Pterin deaminase has been identified in bacterial and fungal species, as well as in mammalian liver tissues, where it plays a role in folate metabolism and cellular signalling. In contrast, sepiapterin deaminase is predominantly found in vertebrate tissues with a high BH4 demand, particularly in the neurological and vascular systems. Structural analyses reveal that both enzymes share the conserved metal-binding characteristics of the amidohydrolase superfamily, with pterin deaminase being a zinc-dependent metalloenzyme. Despite sharing the (β/α)₈-barrel fold and metal-binding catalytic core, subtle variations in active-site residues, such as the substitution of histidine with cysteine, determines their catalytic behavior, metal preference, and redox sensitivity. Comparative kinetic and structural analyses revealed that pterin deaminase displayed broader catalytic flexibility and higher metal tolerance, whereas sepiapterin deaminase maintained strict substrate selectivity and redox regulation. These adaptive differences reflect an evolutionary transition from general pterin degradation to specialized cofactor maintenance and pigment biosynthesis. Beyond their biochemical distinctiveness, both enzymes exhibit emerging biomedical and biotechnological significance. Pterin deaminase in folate catabolism and potential antitumor applications and sepiapterin deaminase in neurotransmitter regulation and pigment-associated disorders. This review provides a detailed structural, catalytic, and physiological perspectives to highlight the evolutionary divergence of pterin deaminase and sepiapterin deaminase within the amidohydrolase fold, and their growing relevance in metabolic and biomedical research. KEY POINTS: • Pterin deaminase and Sepiapterin deaminase play important but different roles in the pteridine metabolic network. • Pterin Deaminase's thermostability and substrate versatility make it a promising biocatalyst for green chemistry, pharmaceutical synthesis, and diagnostic biosensors. • Sepiapterin deaminase -like enzymes in bacteria appear stress-inducible, with expression modulated by oxidative response factors such as SoxRS and fumarate-nitrate reductase (FNR), an adaptive role in redox regulation and biofilm formation.

Indexed as

AminohydrolasesPterinsAnimalsBacteriaBiopterinsCatalytic DomainHydro-LyasesKineticsProtein ConformationSubstrate SpecificityAminohydrolasesBiopterinsHydro-Lyasespterin-4a-carbinolamine dehydratasePterinssapropterinsepiapterinAmidohydrolase superfamilyPteridine metabolismPterin deaminaseSepiapterin deaminaseTetrahydrobiopterin (BH4)

Identifiers

PMID41989482
PMCPMC13197243

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.